Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This is a study that will test a predictive biomarker algorithm based on results from a
previous study. The goal of this study is to integrate clinical, imaging, EEG, and molecular
data across 8 sites to predict treatment outcome for patients experiencing a major depressive
episode (MDE).
Phase:
Phase 4
Details
Lead Sponsor:
University Health Network, Toronto
Collaborators:
Baycrest Centre for Addiction and Mental Health Dalhousie University McGill University McMaster University Queen's University Simon Fraser University Unity Health Toronto University of British Columbia University of Calgary University of Michigan University of Ottawa